About Provivi
Provivi is a company based in Santa Monica (United States) founded in 2013 by Peter Meinhold, Frances Arnold, and Pedro Coelho. Provivi has raised $210.92 million across 15 funding rounds from investors including Corteva Agriscience, BASF and Pioneer Seeds. The company has 1 employees as of March 28, 2024. Provivi offers products and services including Provivi Catalog and Provivi App. Provivi operates in a competitive market with competitors including BioPhero, PheroSyn, Barrix Agro Sciences, Pheronym and ATGC Biotech, among others.
- Headquarter Santa Monica, United States
- Employees 1 as on 28 Mar, 2024
- Founders Peter Meinhold, Frances Arnold, Pedro Coelho
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Provivi India Private Limited
- Date of Incorporation 27 Apr, 2022
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$210.92 M (USD)
in 15 rounds
-
Latest Funding Round
$25.5 M (USD), Series C
Sep 24, 2025
-
Investors
Corteva Agriscience
& 16 more
-
Employee Count
1
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Provivi
Provivi offers a comprehensive portfolio of products and services, including Provivi Catalog and Provivi App.
Catalog providing science-based tools for farmers and sustainability.
App for accessing farming resources and news updates securely.
People of Provivi
Unlock access to complete
Unlock access to complete
Funding Insights of Provivi
Provivi has successfully raised a total of $210.92M across 15 strategic funding rounds. The most recent funding activity was a Series C round of $25.5 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Provivi
Provivi has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include Corteva Agriscience, BASF and Pioneer Seeds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private equity firm
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life sciences, physical sciences, and technology companies
|
Locked | Locked | Locked | |
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked |
Investor details for Provivi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Provivi
Investment portfolio details for Provivi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Provivi
Detailed financials for Provivi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Provivi Comparisons
Peer comparison for Provivi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Provivi
Provivi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioPhero, PheroSyn, Barrix Agro Sciences, Pheronym and ATGC Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Insect pheromones for pest management are produced and supplied.
|
|
| Locked | Locked | Locked |
Provider of pheromone-based integrated pest management solution
|
|
| Locked | Locked | Locked |
Manufacturer of pheromone traps and plant management solutions
|
|
| Locked | Locked | Locked |
Developer of nematode pheromone-based crop protection products
|
|
| Locked | Locked | Locked |
Pest control management services are provided to various customers.
|
Detailed competitors of Provivi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Provivi
Complete news archive for Provivi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Provivi
Provivi was founded in 2013.
Provivi is headquartered in Santa Monica, United States. It is registered at Santa Monica, California, United States.
Pedro Coelho is the current CEO of Provivi. They have also founded this company.
Provivi is a funded company, having raised a total of $210.92M across 15 funding rounds to date.
As of Mar 28, 2024, the latest employee count at Provivi is 1.
Developer of biocatalyst and fermentation technology for pest control. It develops a technology platform that is based on biocatalysts that enable the efficient synthesis of bio-pesticides. The biocatalysts catalyze the transfer of carbenes, nitrenes, and oxides to olefins and carbon-hydrogen bonds thus installing important functional groups, such as cyclopropanes, amines, alcohols, epoxides, sulfoxides, and sulfoximines that feature in various chiral pesticides.
Provivi's top competitors include BioPhero, Pheronym and Barrix Agro Sciences.
Provivi offers Provivi Catalog and Provivi App.
Provivi has 17 investors. Key investors include Corteva Agriscience, BASF, Pioneer Seeds, Gates Foundation, and Temasek.